Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations
Nigel H. Russell(Nottingham University Hospitals NHS Trust), Shankara Paneesha(University of Leeds), Steven Knapper(Cardiff University), Nigel Patton(Guy's and St Thomas' NHS Foundation Trust), Lucy Pemberton, Charlotte S. Wilhelm-Benartzi(Cardiff University), Emily L. Hinson(Cardiff University), Claire Arnold(University of Ulster), Victoria Pechey, Claire Hemmaway(Auckland City Hospital), Pramila Krishnamurthy(King's College London), Sylwia Simpson, Mette Holm, Panagiotis Kottaridis(University College Hospital), Sophie Betteridge(Cardiff University), Dominic Culligan(Aberdeen Royal Infirmary), Amanda Gilkes(Cardiff University), Sylvie Freeman(University of Birmingham), Leanne Berkhan, Jan Maxwell Nørgaard, R Cuthbert, Leona Batten(Institute of Cancer Research), Marianne Tang Severinsen(Aalborg University Hospital), Mike Dennis(The Christie NHS Foundation Trust), Jad Othman(King's College London), Richard Doocey(King's College London), Walid Sadik, Jeffery Smith(University of Liverpool), Priyanka Mehta, Maria Kallenbach, Joanna Canham(Cardiff University), Ulrik Malthe Overgaard(Copenhagen University Hospital), Hans Beier Ommen(Centre de Recherche Jean Pierre Aubert), Nicola Potter(European Bioinformatics Institute), Richard Lovell(King's College London), Peter Bowett, Mary Francis McMullin, Jane Tighe, Shannon Emmett, Donald Milligan(National Health Service), Timothy Hawkins, Jenny I. O. Craig, Damian Finnegan, Alison Milne, Ranjit Dasgupta, Charles Crawley(Addenbrooke's Hospital), Ashok Roy, Jamie Cavenagh(St Bartholomew's Hospital), Richard Dillon(King's College London)
Cited by 40
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750